Board of Advisors
Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort. For more information on how to join our Board of Advisors please email [email protected]
SAN DIEGO BOARD OF ADVISORS
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Jennifer Arnold
Attorney, Advisor, Mediator, Entrepreneur – Jennifer Arnold Law P.C.
Chuck Baum
President, Founder and Head of Research & Development, and Board Member
Mirati Therapeutics
Chuck Baum
President, Founder and Head of Research & Development, and Board Member – Mirati TherapeuticsPresident and Chief Executive Officer
Chuck Baum, M.D., Ph.D.
Scott Bechtler-Levin
Vistage Chair – Vistage San Diego
Sarah Bhagat
Biotech Investor
Sarah Bhagat
Biotech Investor
Greg Bisconti
Vice Chairman, National Life Science Practice Lead – Cushman & Wakefield
Tasia Blazevich
Managing Director – Deloitte
Sarah Boyce
President & CEO – Avidity Biosciences
Brittany Bradrick
COO & CFO – Neurelis, Inc.
Vika Brough
Chief Accounting Officer – Mirador Therapeutics
Ousmane Caba
Partner – PwC
Cris Calsada
Chief Financial Officer – Regulus Therapeutics
Liz Carter
Liz Carter- VP, Business Development, Head of Strategic Transactions & Partnering
Acadia Pharmaceuticals Inc
Liz Carter
Liz Carter- VP, Business Development, Head of Strategic Transactions & Partnering – Acadia Pharmaceuticals Inc
Travis Carter
President – Carter+Co
Joseph Castagnola
Managing Director, Private Wealth Advisor – Morgan Stanley
Jacob Chacko
CEO – ORIC PharmaceuticalsCEO
ORIC Pharmaceuticals
Isan Chen M.D.
President & CEO – MBrace Therapeutics, Inc.
James Christensen
Chief Scientific Officer – Bristol Squibb
Tracy Cole
Biotech Research Scientist
Tracy Cole
Biotech Research Scientist
Tom Coll
Partner – Cooley
Dee Dee DeMan
Chairman & CEO – Bench International
Karen Deschaine
Partner – Wilson Sonsini Goodrich & Rosati
Michael Dudley
President and Chief Executive Officer – QPEX BIOPHARMA
Marc Eiskowitz
Vice President of Business Development – Capital Advisors Group, Inc.
Emma Epes
Partner, Assurance Services – EY
Laure Escoubet
Chief Scientific Officer – Light Horse Therapeutics
Daniel Faga
Chief Executive Officer – AnaptysBio
Robert Flath
VP, Finance & Strategy – Definium Therapeutics
Scott Foote
Managing Director, Life Sciences – Banc of California
Robert Gaan
Chief Investor Relations Officer – Christopher Weil & Company, Inc
Richard Glynne
CSO – Inception Therapeutics
David Goldstein
Chief Executive Officer – Actio Biosciences
Todd Harris
Founder & CEO – Tyra Biosciences
Gerry Hernandez
SVP, Head of Finance – Vividion
Jackie Hernandez, CPA
Founder – Hernandez & Co. Consulting
Zachary Hornby
President & CEO – Boundless Bio, Inc.
Fleming Jones
Managing Director – FlemingMartin Executive Search
David Kabakoff
Executive Partner Private Equity – SOFINNOVA Investments
Ida Khodami
Partner – Two Bear Capital
Craig Knox
Vice Chairman, Western Region Life Science Co-Lead – Savills North America
Neha Krishnamohan
Chief Financial Officer & EVP, Corporate Development – Artiva Biotherapeutics
Ajay Kshatriya
CEO – Aizen Therapeutics
Cathy Lee
EVP, General Counsel and Corporate Secretary – Metacrine
Hugh Leslie
Principal, Life Science & Technology Practice Lead – Marsh McLennan Agency
Alyssa Levin
Chief Financial Officer & Business Officer – Nkarta
Adam Lohr
Partner, and West Coast Life Science Leader – RSM US LLP
Erik Lundh
Co-Founder and Managing Partner – Park Square Executive Search
James Mackay, Ph.D.
President & CEO – Aristea Therapeutics
Mason Matthies
Managing Director – Donnelley Financial Solutions
Jason McDaniel
Partner – CFGI
Emily McDonald
Audit Partner – KPMG
Alana McNulty
Director – Janux Therapeutics
Shelly Meeusen
Chief Science Officer – Velia
Mike Milligan
Managing Director – C3 Risk & Insurance
Hala Mirza
Senior Vice President, Corporate Affairs – Ionis Pharmaceuticals
Scott Moorefield
COO/CBO – Alterome Therapeutics
Eric Murphy, Ph.D
Co-Founder, CEO & CSO – Alterome Therapeutics
Jon Olsen
Partner – Sidley Law
Lina Pitesa Waage
President, Board of Directors – JDRF San Diego Chapter
Ayesha Price
Consultant, Search - Life Sciences – WittKieffer
Alan Prohaska
Regional President – PNC Bank
Bill Rastetter
Chairman – Fate TherapeuticsChairman, Fate
Chairman, Neurocrine
Chairman, Daré
Precillia Redmond
Founder & CEO – Maeve Consulting, LLC
Vickie Reed
Board Member and Audit Chair; Chief Accounting Officer (retired)
Mirati Therapeutics (retired)
Vickie Reed
Board Member and Audit Chair; Chief Accounting Officer (retired) – Mirati Therapeutics (retired)
Brandi Roberts
EVP Finance – Longboard Pharmaceuticals
Mark Rothera
President & CEO – Viracta Therapeutics
Amelia Sanchez
Partner – CGS3 (Crosbie Gliner Schiffman Southard & Swanson LLP)
Mia Sandvoll
Business Development and Strategic Partnerships – The Leadership Edge
Josh Schimmer
Managing Director, Biotechnology Equity Research – Cantor Fitzgerald
Chirag Shah, PharmD
Entrepreneur & CEO/Founder – Stealth Mode Biotech
Linda Sierra
SVP, Business Development – Bench International
Kevin Simonsen
Founder & Principal – Simonsen Legal PC
Jodi Smith-Ungrodt
Partner – EY
Randy Socol
Partner – DLA Piper
Kristin Stafford
SVP, Chief Accounting Officer – Royalty Pharma
Jason Stewart
Founder & CEO – Blake & Michaels
Brian Taggart
Assurance Partner – BDO USA, LLP
Taj Tariq, CPA
Managing Director - Accounting, Transaction Services, & SOX Advisory – CNM LLP
Kristin Taylor
America Thompson
Vice President, Finance & Accounting – Kate Therapeutics
Stacey Tyree
Principal – RE:Align Tenant Strategies
Roberto Vieira
President, Oncology – Corcept Therapeutics
Christian Waage
Executive Vice President – Gossamer Bio
Mark Wiggins
Chief Business Officer – Vaxcyte
Troy Wilson
President & CEO – Kura Oncology
Thomas Woiwode, PhD
Managing Director – Versant Ventures